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In our series of 177 real world patients (223 lesions) who underwent Absorb Bioresorbable
Vascular Scaffold (BVS) implantation, 78 lesions were calcified and tortuous lesions. In four
of these, despite adequate lesion bed preparation, appropriate guiding catheter support
and use of buddy wires, the BVS failed to track through the proximal calcified and tortuous
coronary anatomy (CTCA). “Guide Liner” catheter (GLC) had to be finally used to resuc-
cessfully deliver and implant BVS to the lesion site.
We report for the first time four cases of use of guideliner catheter to successfully
overcome failed delivery of BVS to the lesion site through proximal CTCA, calcified and
tortuous coronary artery (CTCA) lesions treated with Absorb™ BVS. Because the BVS is a
large profile device, certain difficulties were encountered in delivering it through the GLC,
which were finally overcome. We have therefore discussed the ‘lessons and learnt’ and
“salient practice points” to enable successful delivery of BVS through the GLC.
Copyright © 2014, Cardiological Society of India. All rights reserved.1. Introduction
The Absorb™ Bioresorbable Vascular Scaffold (BVS) [Abbott
Vascular, Santa Clara, USA] represents a fascinating
advancement in stent technology for treatment of significant
coronary stenosis with the benefits of ‘best in class’ metallichcare.com, meenakshi.ka
ociety of India. All rightsdrug eluting stents (DES) in the short term and without
leaving behind a permanent metallic implant in the long
term. Based on the first in man studies,1 its subsequent
approval in many countries has lead to its increasing use in
‘real world’ patients with complex coronary artery disease,
which had been excluded from the previous studies. Calci-
fied, tortuous coronary arteries (CTCA) and lesions pose ar@fortishealthcare.com (A. Seth).
reserved.
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because of its larger profile (the 2.5 mm and 3.0 mm diameter
BVS has a crossing profile of 0.06000 and the 3.5 mm diam-
eter; BVS has a crossing profile of 0.06500). Additionally if
there is a failure to deliver the BVS across the lesion, then the
high profile ‘invisible device’ would have to be withdrawn
into the Guide Catheter (GC) with a risk of device dislodge-
ment. Once withdrawn, a new BVS has to be taken for the
second attempt as per the Instruction for Use (IFU Absorb,
Abbott Vascular, Santa Clara, USA). Various ‘tricks’, which
have been well described to overcome failure of stent de-
livery, like better GC support and ‘deep’ intubation, ‘extra
support’ wires and ‘buddy wires’, may also occasionally fail
to deliver a BVS across difficult CTCA. From Jan 2013 to Sep
2013, out of 177 “real world” lesion treated with BVS, 78 le-
sions were calcified or/and had proximal CTCA. Of these the
BVS failed to deliver in four cases despite all efforts and tricks
outlined above. The use of the GuideLiner™ catheter (GLC)
[Vascular Solutions, Minneapolis, USA] a rapid exchange,
coaxial, guide catheter extension device2 finally enabled
successful implantation of BVS. As the BVS is a large profile
device, certain problems were encountered during its use
with GLC. We therefore, describe for the first time the tech-
nical considerations for the use of GLC to deliver Absorb
through the series of four cases. These observations would be
even more vital when delivering BVS through 6F GC via radial
route in CTCA.Fig. 1 e Case 1: (a) and (b) left coronary angiogram in AP crania
tortuosity, (c) use of Guideliner catheter for BVS deployment, an2. Case reports
2.1. Case I
A 72-year-old gentleman with Diabetes and hypertension
presented with exertional angina of 3 months duration. Coro-
nary angiogram (CAG) revealed single vessel 80%calcifiedmid-
Left anterior descending artery (LAD) stenosis. The proximal
LAD was also calcified and had two bends (Fig. 1a and b.)
Rotational atherectomy of LAD was performed with a 1.5 mm
burr. The lesion was then fully pre-dilated with 2.5  12 mm
non-compliant (NC) balloon to 24 atm with no residual steno-
sis. Stenting of LAD was attempted using a 2.5  28 mm BVS
through a 7F extra back up GC and over an All Star™ extra
support wire (Abbott Vascular, Santa Clara, USA) and “Buddy
Wire”. TheBVScouldnot bedelivered to the lesion site andwas
withdrawn. A 7F (6 in 7) GLCwas then gently advanced into the
LADover an inflated balloon for approximately 3 cmacross the
proximal CTCA. A new 2.5  28 mm BVS was then advanced
through the proximal metallic collar of GLC under direct fluro
vision. The BVSwould not enter through the proximal collar of
GLC into its catheter extension due to the guide wire bias or
intertwining, especially as the collar lay in the curved segment
of the arch of the aorta. Because the GLC had already been
advanced through the proximal CTCA of LAD, it was preferred
not to withdraw the GLC to get the collar to a straight segmentl and RAO caudal views showing proximal double calcified
d (d) final result.
Table 1
Case/
Fig. no.
Vessel (v)j
size (mm) j
lesion
stenosis %
(visual
estimate)
GC
shape
and
size
Lesion
preparation
Size of BVS Techniques
used to
deliver BVS
No. of
failed
attempts
to
deliver
BVS
Size
of GL
Technique
used to
deep
intubate the
GLC
Problems faced
during delivery
of BVS through
GLC
Technical
indications
while using
GLC
Final post
dilatation
Complication Follow
up
Case 1
(Fig. 1)
Mid-LAD j
2.5 mm j 80%
7F XB  Rotabaltor
1.5 mm burr
 Pre-dil.:
2.5 mm NC
balloon at
24 atm
2.5  28 mm  Buddy wire:
failed
 Deep intu-
bation GC
 Support
wire
One 7F
(6 in 7)
Deep
intubated
over inflated
balloon
Contrast
injection through
wedged deep
intubated GL
caused
bradycardia/
transient
asystole
Avoid forceful
contrast
injection, during
deep intubation
of GL
2.75  12 mm
NC balloon at
24 atm
None Well at
9-months
Case 2
(Fig. 2)
Mid-LAD j
3.0 mm j80%
7F XB Pre-dil.: 2.5 mm
NC balloon at
24 atm and
3.0 mm NC
balloon at 24 atm
3.0  18 mm
(two BVS
maker to
marker
overlap distal
to proximal)
 Deep intu-
bation GC
 Buddy wire
 Balloon
upsizing HP
pre-
dilatation
Two 7F
(6 in 7)
Deep
intubated
over balloon
shaft
 Difficulty in
entering GLC
through prox-
imal metallic
collar
 Proximal
dissection
 Pulled GC back
by 5 cm to
straighten GL
in aortic arch.
 3.0  12 mm
Xience™ stent
to cover prox-
imal edge
dissection
3.0  12 mm
NC balloon at
24 atm
Proximal LAD
dissection
treated with
3.0  12 mm
Xience™ (Abbott
Vascular, Santa
Clara, USA)
Well at
7-months
Case 3
(Fig. 3)
1 7F JR 3.5 3.0 mm NC
balloon at 20 atm
3.0  18 mm  Deep Intu-
bation GC
 Buddy wire
 Support
wire
Two 6F
(5 in 6)
Deep
intubated
over the two
wires
3.0  18 mm BVS
would not enter
through the
metallic collar of
GL into the
extension tube
GL withdrawn
out of the GC and
BVS preloaded
and the
combination
reinserted and
advanced
3.25  12 mm
NC balloon at
24 atm
None Well at
5-months
Case 4
(Fig. 4)
Mid-RCA j
3.0 mm j 70%
7F JR 3.5 3.0 mm NC
balloon at 20 atm
3.0  18 mm  Deep intu-
bation GC
 Buddy wire
 Support
wire
Two 7F
(5 in 6)
Deep
intubated
over single
support wire
3.0  18 mm BVS
would not enter
through the
metallic collar of
GL into the
extension tube
GL withdrawn till
the metallic
collar lay in
straight
descending aorta
tomake the entry
of BVS in GL
coaxial.
3.25  12 mm
NC balloon at
26 atm
None Well at
3-months
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the LAD. This led to straightening of the proximal segment of
GLC and realignment of the wire at the GLC metallic collar
enabling the BVS to cross the collar and enter to GLC extension
tube.TheBVSwas thensuccessfullydeliveredacross the lesion
through the deep intubated GLC and post dilated with
2.75  12 mm NC balloon upto 20 atm (Fig. 1c and d). The pro-
cedurewas successful and the patient was dischargedwith no
complications and remains well at 9-months follow up.
2.2. Case 2, 3, and 4
The salient angiographic, clinical and procedural difficulties
and solutions are outlined in Table 1.3. Discussion
The benefits of BVS to treat complex lesion subsets especially
calcified lesions remain to be proven and may be speculative.
Yet, as its use expands to more complex anatomy in ‘real
world’ patients, CTCA lesions are regularly encountered.
Optimal implantation and expansion of BVS in calcified lesionFig. 2 e Case 2: (a) AP cranial view showing LAD/D1 bifurcation
caudal view showing proximal edge dissection, and (d) final rerequire adequate lesion and vascular bed preparation with
high pressure balloon dilatations and occasionally the use of
cutting balloons, scoring balloons or rotational atherectomy.
Of equal importance is the vessel tortuousity and calcification
proximal to the lesion as this may provide extreme resistance
and prevent delivery of ‘high profile’ BVS to the lesion. Hence,
appropriate evaluation of the proximal vessel for tortuousity
and calcification, prior to the delivery of BVS, has become
more important than with metallic stents to achieve a suc-
cessful implantation.
Following the approval of BVS in India in December 2012 to
date we have used 223 BVS in 177 patients of which 78 have
been CTCA lesions. We have had to resort to the use of GLC in
four patients, where all attempts to deliver BVS failed. The use
of GLC to deliver BVS and problems encountered has not been
reported in literature before. Our cases provide the following
important and first time technical insights and learnings
specific to the delivery of BVS through GLC:
A) 7F GL (6 in 7F) internal diameter: 0.06200 eAll sizes of BVS
can be delivered through a 7F GLC.
The 3.5 mm BVS is tight fit .The entry of BVS through the
proximal metallic collar of GLC into the guide extensionlesion, (b) use of Guideliner for BVS deployment, (c) LAO
sult.
Fig. 3 e Case 3: (a) and (b): LAO and RAO view showing calcified lesion in mid-RCA, (c) use of Guideliner for BVS deployment,
and (d) final result.
i n d i a n h e a r t j o u rn a l 6 6 ( 2 0 1 4 ) 4 5 3e4 5 8 457tube should be performed under fluro vision and should be
extremely gentle; this is where the large profile BVS espe-
cially the 3.5 mm BVS encounters most resistance.
B) In some cases, the BVSmay not go through the proximal
collar into the distal 20 cm extension as this lies on the
curve of the aortic arch and there may be a guide wire
bias or intertwining. Care should be taken not to force
the BVS through the proximal collar but towithdraw the
GLC back into the GC so that the proximal collar lies in
the straighter segment of thoracic aorta thus making it
more coaxial to allow easier entry of BVS through the
proximal collar of GLC (Case no. 4). Alternatively, leav-
ing the GL deeply intubated, the GC can be withdrawn
out of the coronary artery ostium for 4e5 cm which
straightens the proximal segment of GLC and alters the
guide wire bias at themetallic collar enabling the BVS to
enter into the GLC extension tube (Case 1).
C) 6F GLC (5 in 6F) internal diameter: 0.05600. The 2.5 mm
and 3.0 mm diameter BVS are a ‘tight fit’ and hence willnot enter through the proximal ‘metallic collar’ while
the GLC is in the GC. They can be ‘preloaded’ into the
GLC extension tube outside, prior to entry into the
guiding catheter (GC) and the combination can then be
advanced to the distal end of the GC. From here the GLC
is first advanced deep into the vessel across proximal
tortuousities and then the BVS is advanced to deliver it
to the lesion as was done in our case no. 3.
A 3.5 mm BVS cannot be preloaded into a 6F GLC. This infor-
mation is extremely important as Radial route using 6F GC
is becoming an increasingly popular route for coronary
intervention.
We believe that the GLC is an important and extremely
useful device to enable safe and successful delivery of BVS in
CTCA. Keeping in mind that one would like to avoid the
withdrawal of this ‘invisible’ stent, which should not be
reintroduced once withdrawn out of GC (as per IFU), it is
important to have a successful delivery of BVS to the lesion
Fig. 4 e Case 4: (a) LAO view showing calcified and tortuous lesion in proximal RCA, (b) use of Guideliner for BVS
deployment, and (c) final result.
i n d i a n h e a r t j o u r n a l 6 6 ( 2 0 1 4 ) 4 5 3e4 5 8458site in the first attempt. For this, careful evaluation of calcifi-
cation and tortuosity of the vessel before the lesions and at the
lesion and upfront use of GLC for difficult anatomies keeping
the above technical considerations in mind could lead to
increasing successful implantation of BVS in the ‘real life’
patients with CTCA. Whether BVS will have the same poten-
tial advantages and results in the long term in calcified lesions
comparedwith non-calcified lesions remains to be proven and
is speculative.4. Conclusions
The delivery of BVS through calcified tortuous coronary artery
may be difficult. GLC may be helpful for BVS delivery in such
lesions where other maneuvers have failed. However, as BVS
has different profile and performance characteristics
compared with a metallic stent, certain technicalconsideration described in the paper need to be kept in mind
to enable successful delivery and implantation.Conflicts of interest
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